X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
dense deposit disease (361) 361
humans (336) 336
index medicus (294) 294
membranoproliferative glomerulonephritis (241) 241
urology & nephrology (222) 222
hemolytic-uremic syndrome (177) 177
male (156) 156
female (148) 148
glomerulonephritis (142) 142
complement (139) 139
alternative pathway (129) 129
c3 glomerulopathy (125) 125
eculizumab (105) 105
adult (94) 94
immunology (88) 88
adolescent (87) 87
dense-deposit disease (84) 84
glomerulonephritis, membranoproliferative - pathology (82) 82
middle aged (82) 82
child (80) 80
animals (78) 78
glomerulonephritis, membranoproliferative - immunology (76) 76
macular degeneration (75) 75
nephrology (68) 68
biopsy (62) 62
c3 glomerulonephritis (61) 61
complement factor-h (56) 56
kidney - pathology (55) 55
mutation (55) 55
glomerulonephritis, membranoproliferative - genetics (54) 54
complement factor h - genetics (53) 53
young adult (51) 51
glomerulonephritis type-ii (48) 48
medicine & public health (48) 48
pathology (47) 47
factor-h (46) 46
activation (45) 45
complement c3 - metabolism (45) 45
kidney glomerulus - pathology (45) 45
transplantation (43) 43
factor h (42) 42
kidney transplantation (41) 41
risk factors (41) 41
treatment outcome (40) 40
glomerulonephritis - immunology (39) 39
glomerulonephritis - pathology (39) 39
pediatrics (39) 39
article (38) 38
complement activation (38) 38
kidney diseases (38) 38
abnormalities (37) 37
aged (37) 37
glomerulonephritis, membranoproliferative - diagnosis (37) 37
monoclonal gammopathy (37) 37
c3 nephritic factor (36) 36
complement c3 - analysis (36) 36
glomerulonephritis, membranoproliferative - drug therapy (36) 36
atypical hemolytic uremic syndrome (34) 34
glomerulopathy (34) 34
microscopy, electron (34) 34
research (33) 33
children (32) 32
complement c3 - immunology (32) 32
biochemistry & molecular biology (30) 30
disease (30) 30
mesangiocapillary glomerulonephritis (30) 30
mutations (30) 30
recurrence (30) 30
antibodies, monoclonal, humanized - therapeutic use (29) 29
autoantibodies (29) 29
kidney glomerulus - immunology (29) 29
paroxysmal-nocturnal hemoglobinuria (29) 29
child, preschool (28) 28
glomerulonephritis, membranoproliferative - therapy (28) 28
iga nephropathy (28) 28
complement system proteins - genetics (27) 27
immunosuppressive agents - therapeutic use (27) 27
nephritic factor (27) 27
care and treatment (26) 26
complement system (26) 26
diagnosis (26) 26
genetic predisposition to disease (26) 26
kidney diseases - immunology (26) 26
mice (26) 26
abridged index medicus (25) 25
complement factor h - metabolism (25) 25
complement system proteins - immunology (25) 25
disease progression (25) 25
kidney - immunology (25) 25
proteins (25) 25
renal-transplantation (25) 25
retrospective studies (25) 25
systemic-lupus-erythematosus (25) 25
follow-up studies (24) 24
medicine, general & internal (24) 24
complement abnormalities (23) 23
complement factor h (23) 23
glomerulonephritis, membranoproliferative - etiology (23) 23
nephrotic syndrome (23) 23
prognosis (23) 23
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (466) 466
German (11) 11
Spanish (6) 6
Japanese (2) 2
Korean (2) 2
Polish (2) 2
French (1) 1
Russian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Kidney International, ISSN 0085-2538, 01/2017, Volume 91, Issue 1, pp. 34 - 44
The antiphospholipid syndrome is a common autoimmune disease caused by pathogenic antiphospholipid antibodies, leading to recurrent thrombosis and/or... 
mTORC pathway | vasculopathy | antiphospholipid antibodies | SYSTEMIC-LUPUS-ERYTHEMATOSUS | RECOGNIZE DOMAIN-I | ANTIBODY SYNDROME | TASK-FORCE REPORT | INTERNATIONAL CONSENSUS STATEMENT | BETA-GLYCOPROTEIN I | UROLOGY & NEPHROLOGY | INDUCED FETAL LOSS | RENAL-VEIN THROMBOSIS | ANTI-BETA-GLYCOPROTEIN-I ANTIBODIES | DENSE-DEPOSIT DISEASE | Allografts - blood supply | Kidney - blood supply | Renal Artery Obstruction - immunology | Kidney - pathology | Humans | Immunosuppressive Agents - therapeutic use | Kidney Diseases - diagnosis | Antibodies, Antiphospholipid - immunology | Kidney - immunology | Plasma Exchange | Antiphospholipid Syndrome - complications | Hypertension - etiology | Thrombosis - diagnostic imaging | Allografts - pathology | Angiotensin-Converting Enzyme Inhibitors - therapeutic use | Renal Artery Obstruction - diagnostic imaging | Renal Artery Obstruction - drug therapy | Thrombosis - immunology | Anticoagulants - therapeutic use | Thrombosis - epidemiology | Allografts - immunology | Disease Progression | Antiphospholipid Syndrome - immunology | Kidney Diseases - immunology | Magnetic Resonance Imaging | Renal Artery Obstruction - complications | Animals | Kidney Diseases - therapy | Thrombosis - drug therapy | Angiotensin Receptor Antagonists - therapeutic use | beta 2-Glycoprotein I - immunology | Antiphospholipid Syndrome - therapy | Kidney Transplantation - adverse effects
Journal Article
Journal Article
Kidney International. Supplement, ISSN 0085-2538, 2017, Volume 91, Issue 3, pp. 539 - 551
Journal Article
Journal Article
Kidney International, ISSN 0085-2538, 04/2018, Volume 93, Issue 4, pp. 977 - 985
C3 glomerulonephritis (C3GN) and dense deposit disease comprise the two classes of C3 glomerulopathy. Studies from Europe and Asia have aided our understanding... 
dense deposit disease | glomerulonephritis | C3 glomerulopathy | alternative complement pathway | COMPLEMENT ABNORMALITIES | VARIANTS | PATHOLOGY | MPGN | CONSENSUS REPORT | FEATURES | OXFORD CLASSIFICATION | UROLOGY & NEPHROLOGY | IGA NEPHROPATHY | MONOCLONAL GAMMOPATHY | Complement C3 - analysis | United States - epidemiology | Kidney - pathology | Humans | Middle Aged | Kidney - immunology | Male | Atrophy | Renal Insufficiency, Chronic - epidemiology | Young Adult | Time Factors | Kidney Failure, Chronic - pathology | Adult | Female | Retrospective Studies | Complement Pathway, Alternative - genetics | Kidney - physiopathology | Glomerulonephritis, Membranoproliferative - pathology | Kidney Failure, Chronic - immunology | Renal Insufficiency, Chronic - immunology | Risk Factors | Biomarkers - analysis | Treatment Outcome | Glomerulonephritis, Membranoproliferative - therapy | Remission Induction | Disease Progression | Renal Insufficiency, Chronic - pathology | Autoantibodies - immunology | Glomerulonephritis, Membranoproliferative - immunology | Kidney Failure, Chronic - epidemiology | Biopsy | Complement Pathway, Alternative - immunology | Adolescent | Fibrosis | Glomerulonephritis, Membranoproliferative - epidemiology | Glomerulonephritis | End-stage renal disease | Pediatrics | Autoantibodies | Disease | Patients | Glomerular filtration rate | Histopathology | Microscopy | Complement component C3 | Remission | Kidney diseases | Age
Journal Article